The FDA approved a 21-valent pneumococcal conjugate vaccine (Capvaxive) for preventing invasive pneumococcal disease and pneumococcal pneumonia in adults, Merck announced on Monday. Specifically ...
Pneumococcal vaccines are the most effective way to protect yourself or your child against pneumococcal disease, and may help prevent infections including ear infections, pneumonia (lung infection), ...
Sequential administration of the 13-valent pneumococcal conjugate vaccine (PCV13) and the 23-valent polysaccharide vaccine (PPSV23) led to nonsignificant increases in memory B cells by week 28 in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results